A carregar...
Purinergic Signalling in Parkinson’s Disease: A Multi-target System to Combat Neurodegeneration
Parkinson’s disease (PD) is the second most common neurodegenerative disorder, characterized by progressive loss of dopaminergic neurons that results in characteristic motor and non-motor symptoms. l-3,4 dihydroxyphenylalanine (l-DOPA) is the gold standard therapy for the treatment of PD. However, l...
Na minha lista:
| Publicado no: | Neurochem Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6776560/ https://ncbi.nlm.nih.gov/pubmed/31054067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11064-019-02798-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|